LYMPHOMA, LARGE B-CELL, DIFFUSE
Clinical trials for LYMPHOMA, LARGE B-CELL, DIFFUSE explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA, LARGE B-CELL, DIFFUSE trials appear
Sign up with your email to follow new studies for LYMPHOMA, LARGE B-CELL, DIFFUSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Chemo-Light trio shows promise for elderly lymphoma patients
Disease control OngoingThis phase 2 study tests a new drug combination (rituximab, polatuzumab vedotin, and glofitamab) that uses less chemotherapy than standard treatment. It is designed for people over 60 with aggressive B-cell lymphoma who cannot tolerate full-dose chemo. The goal is to see if this …
Matched conditions: LYMPHOMA, LARGE B-CELL, DIFFUSE
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated May 26, 2026 05:28 UTC
-
Promising new combo therapy targets rare brain cancer
Disease control OngoingThis study tests adding either lenalidomide or ibrutinib to standard chemotherapy for adults aged 18-65 with newly diagnosed primary central nervous system lymphoma (a rare brain cancer). The goal is to improve treatment response before a stem cell transplant. The trial first fin…
Matched conditions: LYMPHOMA, LARGE B-CELL, DIFFUSE
Phase: PHASE1, PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated May 12, 2026 13:42 UTC